Battling the Chimaera: How Much Disclosure of Rare Risks Is Necessary?

Richard L. Prager; Alejandro Murillo Berlioz; Gregory D. Trachiotis; Joseph B. Zwischenberger; Robert M. Sade

doi:10.1016/j.athoracsur.2018.03.076

Battling the Chimaera: How Much Disclosure of Rare Risks Is Necessary?

Richard L. Prager, Alejandro Murillo Berlioz, Gregory D. Trachiotis, Joseph B. Zwischenberger, Robert M. Sade

Research output: Contribution to journal › Editorial

Original language	English
Pages (from-to)	327-332
Number of pages	6
Journal	Annals of Thoracic Surgery
Volume	106
Issue number	2
DOIs	https://doi.org/10.1016/j.athoracsur.2018.03.076
State	Published - Aug 2018

Bibliographical note

Funding Information:
Dr Sade’s role in this publication was supported by the South Carolina Clinical & Translational Research Institute, Medical University of South Carolina’s Clinical and Translational Science Award Number UL1TR001450. The contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Center for Advancing Translational Science of the National Institutes of Health.

ASJC Scopus subject areas

Surgery
Pulmonary and Respiratory Medicine
Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.athoracsur.2018.03.076

Cite this

@article{9b8d4376a9e145d1bafbbb7fdedc78a0,

title = "Battling the Chimaera: How Much Disclosure of Rare Risks Is Necessary?",

author = "Prager, {Richard L.} and {Murillo Berlioz}, Alejandro and Trachiotis, {Gregory D.} and Zwischenberger, {Joseph B.} and Sade, {Robert M.}",

note = "Funding Information: Dr Sade{\textquoteright}s role in this publication was supported by the South Carolina Clinical & Translational Research Institute, Medical University of South Carolina{\textquoteright}s Clinical and Translational Science Award Number UL1TR001450. The contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Center for Advancing Translational Science of the National Institutes of Health. ",

year = "2018",

month = aug,

doi = "10.1016/j.athoracsur.2018.03.076",

language = "English",

volume = "106",

pages = "327--332",

number = "2",

}

TY - JOUR

T1 - Battling the Chimaera

T2 - How Much Disclosure of Rare Risks Is Necessary?

AU - Prager, Richard L.

AU - Murillo Berlioz, Alejandro

AU - Trachiotis, Gregory D.

AU - Zwischenberger, Joseph B.

AU - Sade, Robert M.

N1 - Funding Information: Dr Sade’s role in this publication was supported by the South Carolina Clinical & Translational Research Institute, Medical University of South Carolina’s Clinical and Translational Science Award Number UL1TR001450. The contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Center for Advancing Translational Science of the National Institutes of Health.

PY - 2018/8

Y1 - 2018/8

UR - http://www.scopus.com/inward/record.url?scp=85050116346&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050116346&partnerID=8YFLogxK

U2 - 10.1016/j.athoracsur.2018.03.076

DO - 10.1016/j.athoracsur.2018.03.076

M3 - Editorial

C2 - 29730346

AN - SCOPUS:85050116346

SN - 0003-4975

VL - 106

SP - 327

EP - 332

JO - Annals of Thoracic Surgery

JF - Annals of Thoracic Surgery

IS - 2

ER -

Battling the Chimaera: How Much Disclosure of Rare Risks Is Necessary?

Bibliographical note

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this